Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2014 Jul 15.
Published in final edited form as: Reprod Toxicol. 2013 Apr 17;44:7–14. doi: 10.1016/j.reprotox.2013.03.012

What is in our environment that effects puberty?

Marisa M Fisher 1,*, Erica A Eugster 1
PMCID: PMC4096833  NIHMSID: NIHMS598765  PMID: 23602892

Abstract

Recent studies indicate that the onset of puberty is occurring at increasingly younger ages. Many etiologies have been hypothesized to be involved, but environmental exposures are among the most worrisome. Multiple organizations have endorsed the need to study and provide clinical awareness regarding the effect of a child’s environment on pubertal timing. This review article summarizes the current understanding of the major environmental influences on pubertal timing, focusing on factors for which the most scientific evidence exists. The research reviewed addresses intrinsic factors unique to each individual, naturally occurring endocrine disruptors and chemical endocrine disruptors. In each category, evidence was found for and against the involvement of specific environmental factors on pubertal timing. Ultimately, an individual’s environment is likely comprised of many aspects that collectively contribute to the timing of puberty. The need for research aimed at elucidating the effects of numerous specific yet disparate forms of exposures is emphasized.

Keywords: Puberty timing, Endocrine disrupting chemicals, Phytoestrogens, Phthalates, Bisphenol-A, Pesticides

1. Introduction

Puberty is a time of dramatic developmental changes during which a child’s body progresses through a sequential set of stages to reach mature adult reproductive function. Although the stages of puberty delineated by Tanner et al. in 1969 have not changed, the timing of puberty has become dramatically altered over the last several hundred years. Pubertal maturation begins with increasing GnRH pulses from the hypothalamus that stimulate the production of sex steroids and the progression of secondary sex characteristics resulting in the adult phenotype and reproductive capabilities [1,2]. These pulses herald the end of the dormant hypothalamic–pituitary–gonadal (HPG) axis period of childhood. Breast development, also known as thelarche, was identified by Tanner as the first sign of puberty in girls whereas testicular enlargement and thinning of the scrotum were noted to be the first signs of puberty in boys [3]. Recent research has identified key players involved in triggering puberty such as leptin, kisspeptin, genetics, nutrition and the presence of environmental stimuli [1,2,4,5]. However, precisely what ultimately starts puberty remains enigmatic.

1.1. Secular trends

Historical data have demonstrated a definite decrease in the age at puberty initiation from the 1800s to the mid 1900s [6]. More recent studies show a questionable continual decrease in the age at the start of puberty. These studies have been flawed by issues related to participant selection, poor comparison between groups and a lack of uniform methodology for the assessment of pubertal development [7]. An expert panel in 1994 concluded that there was sufficient evidence to establish a secular trend of earlier thelarche, but not menarche for girls and that there was insufficient evidence for earlier puberty in boys [7]. Indeed, thelarche occurred one year earlier in 2006 as compared to 1991 in a study of 2095 girls in The Copenhagen Puberty Study which was not explained by BMI or hormone levels, leading the researchers to postulate that other factors were involved [8]. These findings have been corroborated in multiple other studies leading to the question of why the onset of thelarche is continuing to decline [913]. An alteration in the tempo of pubertal progression has also been noted as thelarche is occurring earlier but the age of menarche appears to be constant. There are fewer studies evaluating pubertal timing in boys making it harder to form conclusions. In addition, there is no seminal event in boys that is analogous to menarche that allows for retrospective studies on puberty timing. However, pubertal onset in boys was recently brought into question by a large national study examining timing of secondary sexual development in relation to ethnic background [14]. Although boys were observed to develop a pubertal testicular size from 6 months to 2 years earlier than previous norms, some of the study’s findings are internally inconsistent and the age at achievement of Tanner V development was virtually identical to historical reports and unaltered by ethnicity. Nonetheless, these data are intriguing and require further investigation prior to declaring a younger puberty trend in boys. Despite the observations of earlier pubertal onset, most pediatric endocrinologists still adhere to the traditional lower age limits of normal, which are 8 years in girls and 9 years in boys.

1.2. Role of environmental exposures

Multiple studies and cross-sectional reviews have identified environmental exposures and endocrine disruptors as likely contributors to the international secular trend in earlier pubertal development. Evidence for a central role of the environment has included the contemporaneous rapid increase in obesity rates over the last fifty years, geographical differences in pubertal timing, epidemics of earlier puberty concurrent with specific exposures, an increase in manufacturing during this time period and the identification of endocrine disruptors in pollutants and industrial compounds [1517]. Due to heightened concern, a 2008 expert panel was convened by the US Environmental Protection Agency (EPA), the National Institute of Environmental Health Sciences and the Serono Symposia International to examine the relationship between environmental influences and pubertal timing and identify crucial research needs [18]. Endocrine disruptors and body weight were identified as the most concerning factors involved. Although existing data were felt to be highly suggestive of a link between endocrine disruptors and pubertal timing, it has also been readily acknowledged that association does not prove causality [18]. For example, although higher phthalate levels have been found in girls diagnosed with central precocious puberty (CPP) compared to age matched controls without CPP, this does not establish that phthalates cause CPP. Particular areas targeted for future investigation include etiologies of earlier puberty, critical exposure times and mechanisms of disrupting agents [19].

The EPA defined an endocrine disrupting chemical (EDC) as “an exogenous agent that interferes with synthesis, secretion, transport, metabolism, binding action, or elimination of natural blood-borne hormones that are present in the body and are responsible for homeostasis, reproduction, and developmental processes” [20]. The Endocrine Society published a scientific statement in 2009 regarding EDCs and the evidence that they potentially impact many aspects of endocrinology including male and female reproductive organ formation and the HPG axis [20]. The FDA and EPA are in charge of controlling the risk of environmental substances, which is a significantly daunting task in light of how little is known regarding the effects of the numerous chemicals we are exposed to every day [21]. In addition to the Endocrine Society, the European Society for Pediatric Endocrinology and the Pediatric Endocrine Society have also endorsed position statements calling for basic and clinical research, epidemiologic studies and the recognition of EDCs in clinical practice [20,22,23]. These statements highlight the need to examine the consequences of EDCs and other types of environmental exposures during critical periods of development including the prenatal period, infancy and throughout childhood. In addition to post-natal exposures, fetal programming has also been proposed as a possible mechanism for reproductive effects seen later in life due to endocrine disrupting agents. Other mechanisms are thought to be direct effects of environmental exposures on hypothalamic, pituitary or gonadal hormones [17]. Other factors may also be at play as recent scientific advances have brought the relatively young field of epigenetics to attention as a key process that is impacted by environmental EDCs [24]. Epigenetics is the study of changes to the DNA code that do not alter the underlying sequence but induce silencing or activation of gene transcription utilizing DNA methylation and histone deacetylation [24]. The DNA changes can be environmentally induced and inherited by multiple generations independent of subsequent individual exposures [25]. Interestingly, genome wide methylation studies have suggested that epigenetic mechanisms are intrinsically involved in the neuroendocrine control of female puberty [26]. Moreover, both human and animal studies have implicated epigenetic changes resulting from exposures to different types of EDCs in the genesis of altered pubertal timing, as will be discussed in a later section of this review [27,28]. Collectively, there is resounding unanimity among governmental agencies and the scientific community regarding the importance of exploring the link between environmental exposures and human health. This article will summarize the current understanding of the major environmental influences on pubertal timing with a focus on physiologic HPG axis activation rather than variants such as premature adrenarche. We have organized these as intrinsic factors unique to each individual, naturally occurring endocrine disruptors and chemical endocrine disruptors. While an exhaustive description of every purported modifier is beyond the scope of this article, we have aimed to delineate factors within each of these categories for which the most scientific evidence exists.

2. Intrinsic factors unique to individuals

An individual’s genetics have been identified as the primary determinant of the timing of pubertal onset and the tempo of progression. However, it is known that many other aspects of an individual’s life and environment will affect this developmental stage [15,29]. Many association studies examining a host of factors ranging from the intrauterine environment to psychosocial and nutritional exposures have been conducted. As discussed below, these have reported earlier puberty, later puberty or no effect.

2.1.1. Body weight

One of the most enduring observations is that being overweight is associated with earlier puberty in girls. However, these findings have not been substantiated in boys [3033]. In fact, there are actually conflicting data with one study showing slightly earlier puberty in obese boys [34] and others finding precisely the opposite [32,35]. Proposed physiologic mediators of the link between obesity and pubertal timing include leptin, adipocytokines and gut peptides [31,36]

2.1.2. Prenatal growth

There has been increasing interest in the effects of intrauterine growth, birth weight and the pace of early weight gain on fetal programming and subsequent pubertal development. In one study, small for gestational age (SGA) status was found to be an independent risk factor for idiopathic CPP in girls [37]. This effect has been explained through the concept of increased metabolic efficiency imparted by low weight in infancy and evidenced by greater insulin resistance and higher IGF-1 levels in SGA infants who have subsequent rapid weight gain [38,39]. The “thrifty gene” hypothesis states that SGA children are born with the need to take advantage of calories and therefore will gain weight more easily promoting increased BMI and earlier puberty. However, another study reports that girls with a longer and leaner size at birth, not just SGA status, achieve menarche earlier than their shorter and heavier counterparts [40]. The observation that a lower birth weight alone does not increase a child’s chance for earlier puberty but that being longer and lighter at birth does, suggests that under nutrition and possible rapid postnatal weight gain may establish metabolic dysregulation.

2.1.3. Diet

Besides the ingestion of known endocrine disruptors such as phytoestrogens, which are reviewed in the next section, the impact of specific dietary exposures on the timing of puberty has also been examined. Infant nutrition is thought to be optimal when it consists exclusively of breast milk. One large study showed that a one month increase in exclusive breastfeeding reduced the risk of attaining early menarche (<12.1 years) by 6% [41]. However, a subsequent study did not substantiate this and found no association with breastfeeding or childhood milk consumption and an alteration in pubertal timing [42]. Other studies have investigated multiple dietary factors with varying influences on the age of pubertal onset and/or menarche. The 1999–2004 NHANES data found a slight statistically significant negative association between cow’s milk intake during childhood and menarchal age [43]. Women who reported daily milk intake from 5 to 12 years of age experienced menarche 0.317 years earlier than non-milk drinkers [43]. Interestingly, higher animal protein intake was also associated with earlier puberty in both boys and girls in yet another study, although fiber intake had no effect [44]. Finally, vitamin D deficiency in girls has been implicated in shifting the age of menarche downward by ~10 months compared with controls [45]. Additional purported nutritional effects have been nicely reviewed elsewhere [44]. As evidenced by these studies, there are many possible nutritional factors associated with the timing of puberty. It is likely that none of these factors acts alone but rather that a combination of nutritional influences partially directs pubertal timing.

2.1.4. Maternal considerations

In addition to its obvious impact on fetal growth, other aspects of the intrauterine environment are felt to have important implications for future health and development. Two independent studies have found maternal smoking to be associated with earlier puberty [46,47]. This is interesting as maternal smoking is also a known cause of SGA status. Abnormalities in pubertal timing have also been noted in several animal models of neonatal stress felt to be analogous to pre-eclampsia [48]. While this generated interest in the human correlate, no effect of exposure to pre-eclampsia on timing of human puberty has been identified thus far [49]. Reassuringly, the first study to examine reproductive function in children of in vitro fertilization also failed to find any association with altered puberty timing [50]. Studies evaluating in utero exposures are unquestionably important in evaluating future health concerns. Currently this is an open field for further research to identify causality of prenatal exposures on puberty timing.

2.1.5. Psychosocial features

Social stress and deprivation are known to adversely affect psychological as well as physical health in children. Several studies have examined the role of family disruption, particularly a fathers’ absence, on pubertal timing. It is hypothesized that a stressful environment interrupts neuroendocrine control and that this may alter the start of puberty. International adoption and immigration have received significant attention due to an association with earlier puberty hypothesized to be secondary to stressful life events. One study showed a 10–20 times higher risk of CPP in adopted children with decreased risk if the child immigrated with their family and increased risk if adoption occurred after age two [51]. Other studies have demonstrated that a father’s absence and family stressors are independently associated with earlier puberty [37,52,53]. The association of sexual abuse and earlier menarche was explored using data from the Black Women’s Health Study [54]. Women with a history of sexual abuse had a relative risk of 1.27 of menarche prior to age 12 compared with women without a history of abuse. The relative risk increased with increasing episodes of abuse. There was also a slight association of menarche prior to age 12 with physical abuse. Stressful life events impart many health concerns and the evidence for promoting earlier puberty appears to be increasing. This emphasizes the need for improved psychological treatment of children who are victims of abuse or high stress environments.

Based on a significant body of literature, which is summarized in Table 1, there appear to be many aspects of one’s intrinsic environment that are associated with earlier puberty and/or menarche. Differentiating the importance of any single intrinsic factor is daunting given the presence of multiple variables, genetic heterogeneity and inherent recall bias. Although the existing studies are by no means absolute or indicative of causality, they nevertheless demonstrate the need for further investigation.

Table 1.

Effects of intrinsic exposures on puberty timing.

Environmental factor Year Subjects Effect on puberty
Body weight 2008 [30] 8080 women, Canada Older age at menarche (one year older) associated with lower BMI (0.5 less)
Body weight 2009 [32] 156,835 children, Denmark BMI at 7 years of age is inversely correlated with the start and peak of a child’s growth spurt as indicators of puberty timing
Body weight 2012 [33] 2127 girls, Croatia Girls who achieved menarche prior to 11.98 years were of higher BMI than girls who had not
Body weight 2009 [36] 98 children, Netherlands Peak leptin levels occurred prior to peak LH and FSH levels in girls but not in boys
Birth weight 2006 [91] 156 girls, Australia Infants >49.3 cm and <3.325 kg achieved menarche 1 year earlier than shorter, heavier infants
Birth weight 2006 [92] 187 girls, Spain Infants with BW −2 SD or below had earlier menarche, girls with premature adrenarche and BW −2 SD were three times as likely to reach menarche prior to12 years
Birth weight 2001 [40] 997 girls, Philippines BW alone did not affect timing of menarche, but being long (>49 cm) and lean (<3 kg) at birth predicted menses 6 months earlier than the opposite regardless of BMI at 8 years
Birth weight 2012 [37] 78 girls, China SGA status was significantly associated with CPP
Social 2012 [37] 78 girls, China Father’s absence between ages 4 and 6 in a girl’s life was significantly associated with CPP
Social 2006 [51] 655 children, Denmark 10–20 times increased risk of precocious puberty in internationally adopted boys and girls, with even higher risk if adopted after age 2
Social 2008 [52] 161 girls, New Zealand Sisters who were premenstrual prior to familial dysfunction achieved menarche11 months earlier than older sisters
Social 2011 [53] 120 children, Wisconsin Earlier menarche was associated with higher family stress and sympathetic nervous system activation
Social 2009 [54] 35,330 women, USA Positive association between earlier menarche and history of sexual abuse
Intrauterine environment 2011 [46] 3486 boys, Denmark Maternal smoking during pregnancy was associated with earlier puberty
Intrauterine environment 2011 [47] 3169 girls, Denmark Menarche occurred 2.8–4.1 months earlier in girls who were exposed to prenatal maternal smoking (10 + cigarettes/day)
Intrauterine environment 2001 [49] 589 women, Sweden Exposure to pre-eclampsia had no effect on puberty timing
Intrauterine environment 2011 [50] 166 young adults, USA No association of in vitro fertilization with puberty timing
Diet 2011 [41] 994 girls, Philippines Girls who were exclusively breast fed longer had later onset of menarche
Diet 2011 [45] 242 girls, Columbia Vitamin D deficient girls reached menarche 0.8 years earlier than vitamin D sufficient girls
Diet 2011 [43] 2657 women, NHANES Increased milk intake from 5 to 12 years of age was weakly associated with earlier menarche
Diet 2010 [60] 227 children, Germany No association with fiber intake and puberty timing (Dortmund study)
Diet 2012 [82] 112 children, Germany Children with higher vegetable intake reached puberty 7 months later than average and ones with higher animal protein intake reached puberty 7 months earlier than average

3. Naturally occurring endocrine disruptors

Endocrine disruptors can be naturally occurring or synthetic. This section reviews current knowledge regarding the effects of natural endocrine disruptors on pubertal timing. The most notorious of these are plant derived phytoestrogens such as those found in soy. Phytoestrogens share a chemical structure with estrogen and have the ability to be both stimulatory and inhibitory at the level of the estrogen receptor [55]. The prototypes of soy derived phytoestrogens are the isoflavones, daidzein and genistein, which are present in high concentrations in infant soy formula. There has long been concern about potential deleterious effects of a high intake of soy formula on child development [55,56]. Studies show conflicting evidence regarding exposure to soy in infancy and an effect on timing of puberty. While earlier menarche was reported in infants fed soy formula in one study, others found no association between soy formula intake and reproductive outcomes [57]. Similarly, higher serum and urine isoflavone concentrations have been associated with earlier breast development and peak height velocity (a marker of pubertal timing) as well as CPP in some studies, while others have indicated opposite effects with later breast development in girls [5860]. Thus, the true impact of soy ingestion on pubertal timing is far from clear. Other examples of naturally occurring endocrine disruptors include lavender oil, tea tree oil and fennel, all of which have been linked to breast development in prepubertal children presumably due to estrogenic effects [61,62]. These reports have involved oral intake or systemic absorption from topical exposure. Ultimately, other than anecdotal case reports, the relationship between natural endocrine disruptors and pubertal timing remains inconclusive and in need of further study. Table 2 summarizes the major publications devoted to this area of investigation.

Table 2.

Effects of natural exposures on puberty timing.

Environmental Factor Year Subjects Effect on puberty
Skin lotion 2007 [61] 3 boys Boys with gynecomastia had exposure to lavender and tea tree oils which resolved after stopping oils and in vitro studies confirmed estrogenic properties of both oils
Soy formula 2012 [57] 2922 girls, UK Infant girls fed soy formula at <4 months reached menarche earlier (4 months) than girls not fed soy or fed soy later than 4 months
Soy formula 2001 [93] 811 adults, Iowa In recall, no difference in timing of menarche or breast development in women fed exclusive soy vs. cow’s milk formula in infancy
Soy formula 2004 [94] 48 children, Italy No effect of >6 months of soy formula feeding on precocious puberty, gynecomastia, bone age, estradiol levels
Fennel 2008 [62] 4 girls, Turkey Premature thelarche occurred in girls given goeniculum vulgare tea and resolved when stopped
Isoflavones 2011 [58] 108 girls, Korea Girls with CPP showed significantly higher serum isoflavone (daidzein, genistein and total isoflavone) concentrations than controls
Phytoestrogens 2008 [59] 192 girls, New York Higher levels of phytoestrogens (daidzein, genistein, enterolactone) were associated with later onset of breast development
Phytoestrogens 2010 [60] 227 children, Germany Girls who had the highest urinary markers of phytoestrogen intake achieved breast development (0.7 years) and peak height velocity (0.6 years) later than girls with less phytoestrogen intake (Dortmund study)

4. Chemical endocrine disruptors

Although there are a multitude of chemical toxins in our environment, a few in particular have been implicated as having endocrine disrupting attributes. The classic example was an accidental exposure of over 4000 individuals in Michigan in the early 1970s to polybrominated biphenyls (PBBs) thru cattle feed contamination [63]. The exposed women and their offspring have been extensively studied. The maternal cohort had serum PBB levels measured providing the ability to calculate future serum concentrations using the half life, and therefore allowing precise association studies to be performed. Girls exposed to high PBB levels in utero reached menarche at 11.6 years compared to 12.2–12.6 years in girls with low exposure [63]. Many other studies have examined the relationship between chemical EDCs and the timing of puberty, and several extensive reviews have now been published [1517,64]. The impact of epigenetics on the field of chemical EDCs has increasingly been investigated in animal studies. In one study, multiple environmental pollutants were given to gestating female rats at a time point when sex differentiation occurs in the fetus [28]. Notably, no toxic effects were seen in the gestating females and the sex ratios of their litters were unchanged. However, first and second generation offspring exhibited marked alterations in pubertal timing depending on the gender and the specific exposure involved. Most intriguing was the finding that the third generation females also experienced earlier puberty after exposure to BPA/phthalate mixture, dioxin and jet fuel. This demonstrates a transgenerational inherited effect as the third generation had no direct contact with the initial EDCs. Thus, although epigenetic changes appear to be dependent on the timing of the environmental exposure that induces them, the evidence suggests that they are also heritable and persist for generations without further exposure [65]. Experts in this field believe that we are also on the brink of confirming the existence of this phenomenon in humans, not only as it relates to pubertal timing but to a whole host of adverse human secular trends and diseases as well. This section will specifically focus on three of the most widely studied chemical EDCs which are phthalates, bisphenol-A (BPA) and pesticides.

4.1.1. Phthalates

Phthalates are chemicals that are used in plastics to add flexibility [66]. They are found in toys, construction materials and clothing as higher molecular weight compounds and in solvents, cosmetics and pharmaceuticals in low molecular weight forms [64]. Human exposure can occur through oral, inhaled, IV and topical routes and is extremely prevalent [64]. A Danish study found urine samples from 129 healthy children to be nearly universally contaminated by 11 different phthalate metabolites [67]. The metabolites identified with the highest measured levels were dibutyl phthalate and di-(2-ethylhexyl) phthalate. Although the endocrine disrupting mechanism of phthalates is not fully understood, studies indicate possible anti-androgenic effects as well as estrogen agonistic and antagonistic activities [6872]. Multiple association studies have evaluated the effect of phthalates on pubertal timing in humans. In general, phthalates have been associated with earlier puberty, but some studies are not in agreement. Higher urine and serum phthalate levels in girls have been linked to both isolated early breast development [73] as well as CPP in a study in Puerto Rico where the incidence of premature thelarche is the highest in the world [74]. In contrast, several other studies have found no association between phthalate levels and the timing of thelarche or central puberty [67,68,75]. A recent study evaluated phthalate effects in boys. Forty boys diagnosed with pubertal gynecomastia showed significantly higher serum phthalate levels than controls although no association was seen between the phthalate level and serum hormone concentrations [71]. Studies reporting an association between phthalates and puberty are summarized in Table 3. Further exploration is clearly warranted in order to draw definitive conclusions.

Table 3.

Effects of chemical endocrine disruptors on puberty timing.

Agent Year Subjects Effect on puberty
Phthalates 2009 [73] 89 girls, Taiwan Higher phthalate metabolite levels were seen in girls with premature thelarche
Phthalates 2000 [74] 76 girls, Puerto Rico Premature thelarche was associated with higher phthalate levels
Phthalates 2007 [95] 210 girls, Shanghai Higher phthalate levels are in girls with CPP
Phthalates 2010 [71] 61 pubertal boys, Turkey Higher phthalate metabolite levels associated with pubertal gynecomastia in boys
Phthalates 2012 [68] 750 girls, 25 with precocious puberty, Denmark No association of phthalate levels and precocious puberty
Phthalates 2010 [75] 56 girls, USA No association with phthalate levels and CPP
Phthalates 2011 [74] 300 women, New York Association between hair oil use and perms with earlier menarche
Bisphenol-A 2010 [79] 1151 girls, New York, Ohio, California No effect of BPA on breast development
Bisphenol-A 2010 [80] 210 girls, Shanghai Higher BPA levels in girls with CPP
DDE 2004 [85] 151 girls, Michigan Increase in serum DDE of 15 mcg/l associated with decreased age at menarche by 1 year
DDE 2012 [37] 78 patients, China Higher DDE levels slightly associated with CPP
DDT 2005 [83] 446 women, China Higher DDT serum levels associated with earlier menarche
DDE 2001 [84] 145 children, Belgium CPP patients who had immigrated to Belgium had higher DDE levels
DDE 2008 [59] 192 girls, New York No association of DDE urine levels and breast advancement
DDE 2005 [86] 138 girls, New York, Canada No association of DDE with menarche timing
DDE 2012 [96] 94 girls, Italy No association of DDE with precocious puberty

4.1.2. BPA

BPA is a compound used in epoxy resins and polycarbonate plastics [76]. It can be found in Tupperware™, plastic bottles, food cans and medical products and at high temperatures escapes from its solid material into the containers contents [64]. The main source of human exposure is through food contamination from plastic packaging [76]. BPA was incidentally found to interact with the estrogen receptor when an interfering substance (BPA) was identified in Saccharomyces culture in polycarbonate flasks [77]. A headline article published in Nature in 1999 read: “Exposure to bisphenol A advances puberty” [78]. This study demonstrated premature first estrus in mice that were born to mothers fed BPA. However, human studies are sparse and have yet to fully identify BPA as a cause of earlier puberty. In one study of 1151 girls, the effects of 5 different phenol environmental toxins were examined [79]. Although BPA had no influence on breast development, another phenol compound, benzophenone 3, was associated with earlier onset of secondary sexual characteristics, yet no evidence for a dose response effect was found. Another study found significantly higher serum levels of BPA in girls with CPP which were also correlated with increased uterine and ovarian volumes [80]. Reviewed studies are described in Table 3. Given these inconsistent results, more human studies are needed to definitively implicate BPA in the alteration of pubertal timing. Nonetheless, many plastic products are now being marketed as BPA-free as the consumer becomes increasingly aware of health concerns from exogenous chemicals.

4.1.3. Pesticides

Humans are exposed to numerous pesticides through everyday activities and occupations. Over 100 pesticide compounds have been identified as endocrine disruptors and human consumption of them has nearly quadrupled in the last 40 years [81]. Several excellent reviews describe a multitude of different chemicals in pesticides [16,81]. This section focuses on dichlorodiphenyltrichloroethane (DDT) and its metabolite dichlorodiphenyl dichloroethane (DDE), the most studied EDC in pesticides. Even though DDT was banned in the US in the 1970s, it is still used in developing countries today [82]. Additionally, it can still be found in humans across the world as it is stored in adipose tissue with an average half life of 10 years [82,83].

Several studies have found that exposure to DDT and its metabolite DDE are associated with a younger age of puberty as evidenced by earlier menarche or thelarche [37,83]. One such study evaluated children diagnosed with CPP and found higher plasma levels of DDE in those who were adopted or immigrated from foreign countries compared with ones native to the country [84]. This led the authors to infer that the children were exposed to higher environmental pesticides in their prior countries resulting in CPP. Another study has evaluated extrapolated maternal DDT levels and the association with menarchal timing in exposed female offspring. Women who were exposed to higher levels of DDE in utero (by 15 mcg) reached menarche at younger ages than women with lower levels of exposure [85]. However, the association’s significance disappeared when weight at menarche was controlled for. As increased weight is known to contribute to earlier puberty in females it is unknown whether DDT induces pubertal changes intrinsically or through causing increased weight gain.

Other studies have refuted the above findings and shown no association of DDT exposure with earlier pubertal development. These have included studies of serum DDE levels in girls in farming and urban areas as well as those living near the St Lawrence River in New York, Ontario and Quebec where animals have been found with levels of DDE that exceed the FDA’s upper limit for human consumption [86]. Similarly, girls in New York City were evaluated at 9 years of age for stage of breast development and no association was found with DDE levels [59]. Lastly, the impact of prenatal DDT exposure on pubertal development in boys was examined using stored maternal serum. No association between prenatal maternal DDT levels and height, BMI, skeletal age, serum testosterone or DHEAS was found [87]. Studies reporting the effects of DDT and DDE on puberty are reviewed in Table 3.

As the available studies investigating the effects of pesticides on pubertal timing are inconsistent it is difficult to make any sound conclusions. This is also the case for many other worrisome observations pertaining to human health in which exposure to EDCs has been implicated as having a potential causative effect. These include the current epidemics of obesity and diabetes, increasing rates of cryptorchidism in infant boys as well as declining fertility rates, semen quality and birth weight in the US and elsewhere [8890]. Further factors complicating this area of research are that EDCs likely have different endocrine disrupting abilities at different concentrations, exposure amounts, developmental time periods and precise chemical make-up. Despite these formidable obstacles, further study is imperative.

5. Conclusion

In summary, multiple lines of evidence exist to suggest a central role of environmental exposures in the modulation of human pubertal timing. From in utero to nutritional to environmental factors, there are many potential avenues for endocrine disruptors to affect the timing of puberty in girls and boys. However, with the possible exception of obesity in girls, the overall effects of any one factor have been reputed and disputed in different studies which have often reported conflicting results. Therefore, it would be naive to propose that any one factor solely changes the timing of puberty. It is much more likely that many factors have small individual effects acting in concert with one another and that the combination of influences in each individual is what determines pubertal timing. As described earlier in this article, several international societies have put forth position statements on the importance of future research into the effect of environmental exposures on pubertal timing. Prospective studies should also focus on the burgeoning field of epigenetics where we may be able to identify mechanisms for polygenic control of not only puberty but of other aspects of the reproductive endocrine system as well. It will be imperative to investigate which specific exposures and at what points in an individual’s development the effects are the most harmful. These studies are difficult to carry out in humans and initial information may still need to come from animal studies that pave the way for targeted evaluation in humans. The most important conclusion is that further study is needed to address the question of what environmental factors affect puberty and how we can best eliminate relevant exposures with the goal of maximizing the health and well-being of today’s children and future generations to come.

Abbreviations

HPG

hypothalamic–pituitary–gonadal

EDC

endocrine disrupting chemical

EPA

environmental protection agency

FDA

food and drug administration

SGA

small for gestational age

CPP

central precocious puberty

PBB

polybrominated biphenyls

BPA

bisphenol-A

DDT

dichlorodiphenyl-trichloroethane

DDE

dichlorodiphenyl dichloroethane

Footnotes

Conflict of interest

The authors have nothing to disclose.

References

  • 1.Bordini B, Rosenfield RL. Normal pubertal development. Part I: the endocrine basis of puberty. Pediatr Rev. 2011;32:223–9. doi: 10.1542/pir.32-6-223. [DOI] [PubMed] [Google Scholar]
  • 2.Nebesio TD, Eugster EA. Current concepts in normal and abnormal puberty. Curr Probl Pediatr Adolesc Health Care. 2007;37:50–72. doi: 10.1016/j.cppeds.2006.10.005. [DOI] [PubMed] [Google Scholar]
  • 3.Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in boys. Arch Dis Child. 1970;45:13–23. doi: 10.1136/adc.45.239.13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Tena-Sempere M. The roles of kisspeptins and G protein-coupled receptor-54 in pubertal development. Curr Opin Pediatr. 2006;18:442–7. doi: 10.1097/01.mop.0000236396.79580.cc. [DOI] [PubMed] [Google Scholar]
  • 5.Garcia-Mayor RV, Andrade MA, Rios M, Lage M, Dieguez C, Casanueva FF. Serum leptin levels in normal children: relationship to age, gender, body mass index, pituitary–gonadal hormones, and pubertal stage. J Clin Endocrinol Metab. 1997;82:2849–55. doi: 10.1210/jcem.82.9.4235. [DOI] [PubMed] [Google Scholar]
  • 6.Wyshak G, Frisch RE. Evidence for a secular trend in age of menarche. N Engl J Med. 1982;306:1033–5. doi: 10.1056/NEJM198204293061707. [DOI] [PubMed] [Google Scholar]
  • 7.Euling SY, Herman-Giddens ME, Lee PA, Selevan SG, Juul A, Sorensen TI, et al. Examination of US puberty-timing data from 1940 to 1994 for secular trends: panel findings. Pediatrics. 2008;121(Suppl 3):S172–91. doi: 10.1542/peds.2007-1813D. [DOI] [PubMed] [Google Scholar]
  • 8.Aksglaede L, Sorensen K, Petersen JH, Skakkebaek NE, Juul A. Recent decline in age at breast development: the Copenhagen Puberty Study. Pediatrics. 2009;123:e932–9. doi: 10.1542/peds.2008-2491. [DOI] [PubMed] [Google Scholar]
  • 9.Biro FM, Galvez MP, Greenspan LC, Succop PA, Vangeepuram N, Pinney SM, et al. Pubertal assessment method and baseline characteristics in a mixed longitudinal study of girls. Pediatrics. 2010;126:e583–90. doi: 10.1542/peds.2009-3079. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Herman-Giddens ME. The decline in the age of menarche in the United States: should we be concerned? J Adolesc Health. 2007;40:201–3. doi: 10.1016/j.jadohealth.2006.12.019. [DOI] [PubMed] [Google Scholar]
  • 11.Herman-Giddens ME, Slora EJ, Wasserman RC, Bourdony CJ, Bhapkar MV, Koch GG, et al. Secondary sexual characteristics and menses in young girls seen in office practice: a study from the Pediatric Research in Office Settings network. Pediatrics. 1997;99:505–12. doi: 10.1542/peds.99.4.505. [DOI] [PubMed] [Google Scholar]
  • 12.Kaplowitz PB, Oberfield SE. Reexamination of the age limit for defining when puberty is precocious in girls in the United States: implications for evaluation and treatment. Drug and Therapeutics and Executive Committees of the Lawson Wilkins Pediatric Endocrine Society Pediatrics. 1999;104:936–41. doi: 10.1542/peds.104.4.936. [DOI] [PubMed] [Google Scholar]
  • 13.Rosenfield RL, Bachrach LK, Chernausek SD, Gertner JM, Gottschalk M, Hardin DS, et al. Current age of onset of puberty. Pediatrics. 2000;106:622–3. doi: 10.1542/peds.106.3.622. [DOI] [PubMed] [Google Scholar]
  • 14.Herman-Giddens ME, Steffes J, Harris D, Slora E, Hussey M, Dowshen SA, et al. Secondary sexual characteristics in boys: data from the pediatric research in office settings network. Pediatrics. 2012;130:e1058–68. doi: 10.1542/peds.2011-3291. [DOI] [PubMed] [Google Scholar]
  • 15.Toppari J, Juul A. Trends in puberty timing in humans and environmental mod-ifiers. Mol Cell Endocrinol. 2010;324:39–44. doi: 10.1016/j.mce.2010.03.011. [DOI] [PubMed] [Google Scholar]
  • 16.Ozen S, Darcan S. Effects of environmental endocrine disruptors on pubertal development. J Clin Res Pediatr Endocrinol. 2011;3:1–6. doi: 10.4274/jcrpe.v3i1.01. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Schoeters G, Den Hond E, Dhooge W, van Larebeke N, Leijs M. Endocrine disrupt-ors and abnormalities of pubertal development. Basic Clin Pharmacol Toxicol. 2008;102:168–75. doi: 10.1111/j.1742-7843.2007.00180.x. [DOI] [PubMed] [Google Scholar]
  • 18.Euling SY, Selevan SG, Pescovitz OH, Skakkebaek NE. Role of environmental factors in the timing of puberty. Pediatrics. 2008;121(Suppl 3):S167–71. doi: 10.1542/peds.2007-1813C. [DOI] [PubMed] [Google Scholar]
  • 19.Buck Louis GM, Gray LE, Jr, Marcus M, Ojeda SR, Pescovitz OH, Witchel SF, et al. Environmental factors and puberty timing: expert panel research needs. Pediatrics. 2008;121(Suppl 3):S192–207. doi: 10.1542/peds.1813E. [DOI] [PubMed] [Google Scholar]
  • 20.Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, Hauser R, Prins GS, Soto AM, et al. Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr Rev. 2009;30:293–342. doi: 10.1210/er.2009-0002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Crinnion WJ. The CDC fourth national report on human exposure to environmental chemicals: what it tells us about our toxic burden and how it assists environmental medicine physicians. Altern Med Rev. 2010;15:101–8. [PubMed] [Google Scholar]
  • 22.Assessing chemical risk: societies offer expertise. Science. 2011;331:1136. doi: 10.1126/science.331.6021.1136-a. [DOI] [PubMed] [Google Scholar]
  • 23.Skakkebaek NE, Toppari J, Soder O, Gordon CM, Divall S, Draznin M. The exposure of fetuses and children to endocrine disrupting chemicals: a European Society for Paediatric Endocrinology (ESPE) and Pediatric Endocrine Society (PES) call to action statement. J Clin Endocrinol Metab. 2011;96:3056–8. doi: 10.1210/jc.2011-1269. [DOI] [PubMed] [Google Scholar]
  • 24.Tena-Sempere M. Deciphering puberty: novel partners, novel mechanisms. Eur J Endocrinol. 2012;167:733–47. doi: 10.1530/EJE-12-0669. [DOI] [PubMed] [Google Scholar]
  • 25.Jirtle RL, Skinner MK. Environmental epigenomics and disease susceptibility. Nat Rev Genet. 2007;8:253–62. doi: 10.1038/nrg2045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Ojeda SR, Lomniczi A, Sandau U, Matagne V. New concepts on the control of the onset of puberty. Endocr Dev. 2010;17:44–51. doi: 10.1159/000262527. [DOI] [PubMed] [Google Scholar]
  • 27.Li Y, Tollefsbol TO. Impact on DNA methylation in cancer prevention and therapy by bioactive dietary components. Curr Med Chem. 2010;17:2141–51. doi: 10.2174/092986710791299966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Manikkam M, Guerrero-Bosagna C, Tracey R, Haque MM, Skinner MK. Trans-generational actions of environmental compounds on reproductive disease and identification of epigenetic biomarkers of ancestral exposures. PLoS ONE. 2012;7:e31901. doi: 10.1371/journal.pone.0031901. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Aksglaede L, Olsen LW, Sorensen TI, Juul A. Forty years trends in timing of pubertal growth spurt in 157,000 Danish school children. PLoS ONE. 2008;3:e2728. doi: 10.1371/journal.pone.0002728. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Harris MA, Prior JC, Koehoorn M. Age at menarche in the Canadian population: secular trends and relationship to adulthood BMI. J Adolesc Health. 2008;43:548–54. doi: 10.1016/j.jadohealth.2008.07.017. [DOI] [PubMed] [Google Scholar]
  • 31.Wagner IV, Sabin MA, Pfaffle RW, Hiemisch A, Sergeyev E, Korner A, et al. Effects of obesity on human sexual development. Nat Rev Endocrinol. 2012;8:246–54. doi: 10.1038/nrendo.2011.241. [DOI] [PubMed] [Google Scholar]
  • 32.Aksglaede L, Juul A, Olsen LW, Sorensen TI. Age at puberty and the emerging obesity epidemic. PLoS ONE. 2009;4:e8450. doi: 10.1371/journal.pone.0008450. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Bralic I, Tahirovic H, Matanic D, Vrdoljak O, Stojanovic-Spehar S, Kovacic V, et al. Association of early menarche age and overweight/obesity. J Pediatr Endocrinol Metab. 2012;25:57–62. doi: 10.1515/jpem-2011-0277. [DOI] [PubMed] [Google Scholar]
  • 34.Tinggaard J, Mieritz MG, Sorensen K, Mouritsen A, Hagen CP, Aksglaede L, et al. The physiology and timing of male puberty. Curr Opin Endocrinol Diabetes Obes. 2012;19:197–203. doi: 10.1097/MED.0b013e3283535614. [DOI] [PubMed] [Google Scholar]
  • 35.Lee PA. Normal ages of pubertal events among American males and females. J Adolesc Health Care. 1980;1:26–9. doi: 10.1016/s0197-0070(80)80005-2. [DOI] [PubMed] [Google Scholar]
  • 36.Rutters F, Nieuwenhuizen AG, Verhoef SP, Lemmens SG, Vogels N, Westerterp-Plantenga MS. The relationship between leptin, gonadotropic hormones, and body composition during puberty in a Dutch children cohort. Eur J Endocrinol. 2009;160:973–8. doi: 10.1530/EJE-08-0762. [DOI] [PubMed] [Google Scholar]
  • 37.Deng F, Tao FB, Liu DY, Xu YY, Hao JH, Sun Y, et al. Effects of growth environments and two environmental endocrine disruptors on children with idiopathic precocious puberty. Eur J Endocrinol. 2012;166:803–9. doi: 10.1530/EJE-11-0876. [DOI] [PubMed] [Google Scholar]
  • 38.Soto N, Bazaes RA, Pena V, Salazar T, Avila A, Iniguez G, et al. Insulin sensitivity and secretion are related to catch-up growth in small-for-gestational-age infants at age 1 year: results from a prospective cohort. J Clin Endocrinol Metab. 2003;88:3645–50. doi: 10.1210/jc.2002-030031. [DOI] [PubMed] [Google Scholar]
  • 39.Fail CHD, Pandit AN, Law CM, Yajnik CS, Clark PM, Breier B, et al. Size at birth and plasma insulin-like growth-factor-1 concentrations. Arch Dis Child. 1995;73:287–93. doi: 10.1136/adc.73.4.287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Adair LS. Size at birth predicts age at menarche. Pediatrics. 2001;107:E59. doi: 10.1542/peds.107.4.e59. [DOI] [PubMed] [Google Scholar]
  • 41.Al-Sahab B, Adair L, Hamadeh MJ, Ardern CI, Tamim H. Impact of breastfeeding duration on age at menarche. Am J Epidemiol. 2011;173:971–7. doi: 10.1093/aje/kwq496. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Kwok MK, Leung GM, Lam TH, Schooling CM. Breastfeeding, childhood milk consumption, and onset of puberty. Pediatrics. 2012;130:e631–9. doi: 10.1542/peds.2011-3697. [DOI] [PubMed] [Google Scholar]
  • 43.Wiley AS. Milk intake and total dairy consumption: associations with early menarche in NHANES 1999–2004. PLoS ONE. 2011;6:e14685. doi: 10.1371/journal.pone.0014685. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Cheng G, Buyken AE, Shi L, Karaolis-Danckert N, Kroke A, Wudy SA, et al. Beyond overweight: nutrition as an important lifestyle factor influencing timing of puberty. Nutr Rev. 2012;70:133–52. doi: 10.1111/j.1753-4887.2011.00461.x. [DOI] [PubMed] [Google Scholar]
  • 45.Villamor E, Marin C, Mora-Plazas M, Baylin A. Vitamin D deficiency and age at menarche: a prospective study. Am J Clin Nutr. 2011;94:1020–5. doi: 10.3945/ajcn.111.018168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Ravnborg TL, Jensen TK, Andersson AM, Toppari J, Skakkebaek NE, Jorgensen N. Prenatal and adult exposures to smoking are associated with adverse effects on reproductive hormones, semen quality, final height and body mass index. Hum Reprod. 2011;26:1000–11. doi: 10.1093/humrep/der011. [DOI] [PubMed] [Google Scholar]
  • 47.Shrestha A, Nohr EA, Bech BH, Ramlau-Hansen CH, Olsen J. Smoking and alcohol use during pregnancy and age of menarche in daughters. Hum Reprod. 2011;26:259–65. doi: 10.1093/humrep/deq316. [DOI] [PubMed] [Google Scholar]
  • 48.Knox AM, Li XF, Kinsey-Jones JS, Wilkinson ES, Wu XQ, Cheng YS, et al. Neonatal lipopolysaccharide exposure delays puberty and alters hypothalamic Kiss1 and Kiss1r mRNA expression in the female rat. J Neuroendocrinol. 2009;21:683–9. doi: 10.1111/j.1365-2826.2009.01885.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Ros HS, Lichtenstein P, Ekbom A, Cnattingius S. Tall or short? Twenty years after preeclampsia exposure in utero: comparisons of final height, body mass index, waist-to-hip ratio, and age at menarche among women, exposed and unexposed to preeclampsia during fetal life. Pediatr Res. 2001;49:763–9. doi: 10.1203/00006450-200106000-00008. [DOI] [PubMed] [Google Scholar]
  • 50.Beydoun HA, Sicignano N, Beydoun MA, Bocca S, Stadtmauer L, Oehninger S. Pubertal development of the first cohort of young adults conceived by in vitro fertilization in the United States. Fertil Steril. 2011;95:528–33. doi: 10.1016/j.fertnstert.2010.04.057. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Teilmann G, Pedersen CB, Skakkebaek NE, Jensen TK. Increased risk of precocious puberty in internationally adopted children in Denmark. Pediatrics. 2006;118:e391–9. doi: 10.1542/peds.2005-2939. [DOI] [PubMed] [Google Scholar]
  • 52.Tither JM, Ellis BJ. Impact of fathers on daughters’ age at menarche: a genetically and environmentally controlled sibling study. Dev Psychol. 2008;44:1409–20. doi: 10.1037/a0013065. [DOI] [PubMed] [Google Scholar]
  • 53.Ellis BJ, Shirtcliff EA, Boyce WT, Deardorff J, Essex MJ. Quality of early family relationships and the timing and tempo of puberty: effects depend on biological sensitivity to context. Dev Psychopathol. 2011;23:85–99. doi: 10.1017/S0954579410000660. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Wise LA, Palmer JR, Rothman EF, Rosenberg L. Childhood abuse and early menarche: findings from the black women’s health study. Am J Public Health. 2009;99(Suppl 2):S460–6. doi: 10.2105/AJPH.2008.149005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Jefferson WN, Patisaul HB, Williams CJ. Reproductive consequences of developmental phytoestrogen exposure. Reproduction. 2012;143:247–60. doi: 10.1530/REP-11-0369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Merritt RJ, Jenks BH. Safety of soy-based infant formulas containing isoflavones: the clinical evidence. J Nutr. 2004;134:1220S–4S. doi: 10.1093/jn/134.5.1220S. [DOI] [PubMed] [Google Scholar]
  • 57.Adgent MA, Daniels JL, Rogan WJ, Adair L, Edwards LJ, Westreich D, et al. Early-life soy exposure and age at menarche. Paediatr Perinat Epidemiol. 2012;26:163–75. doi: 10.1111/j.1365-3016.2011.01244.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Kim J, Kim S, Huh K, Kim Y, Joung H, Park M. High serum isoflavone concentrations are associated with the risk of precocious puberty in Korean girls. Clin Endocrinol (Oxf) 2011;75:831–5. doi: 10.1111/j.1365-2265.2011.04127.x. [DOI] [PubMed] [Google Scholar]
  • 59.Wolff MS, Britton JA, Boguski L, Hochman S, Maloney N, Serra N, et al. Environmental exposures and puberty in inner-city girls. Environ Res. 2008;107:393–400. doi: 10.1016/j.envres.2008.03.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Cheng G, Remer T, Prinz-Langenohl R, Blaszkewicz M, Degen GH, Buyken AE. Relation of isoflavones and fiber intake in childhood to the timing of puberty. Am J Clin Nutr. 2010;92:556–64. doi: 10.3945/ajcn.2010.29394. [DOI] [PubMed] [Google Scholar]
  • 61.Henley DV, Lipson N, Korach KS, Bloch CA. Prepubertal gynecomastia linked to lavender and tea tree oils. N Engl J Med. 2007;356:479–85. doi: 10.1056/NEJMoa064725. [DOI] [PubMed] [Google Scholar]
  • 62.Turkyilmaz Z, Karabulut R, Sonmez K, Can Basaklar A. A striking and frequent cause of premature thelarche in children: Foeniculum vulgare. J Pediatr Surg. 2008;43:2109–11. doi: 10.1016/j.jpedsurg.2008.07.027. [DOI] [PubMed] [Google Scholar]
  • 63.Blanck HM, Marcus M, Tolbert PE, Rubin C, Henderson AK, Hertzberg VS, et al. Age at menarche and tanner stage in girls exposed in utero and postnatally to polybrominated biphenyl. Epidemiology. 2000;11:641–7. doi: 10.1097/00001648-200011000-00005. [DOI] [PubMed] [Google Scholar]
  • 64.Roy JR, Chakraborty S, Chakraborty TR. Estrogen-like endocrine disrupting chemicals affecting puberty in humans – a review. Med Sci Monit. 2009;15:RA137–45. [PubMed] [Google Scholar]
  • 65.Zama AM, Uzumcu M. Epigenetic effects of endocrine-disrupting chemicals on female reproduction: an ovarian perspective. Front Neuroendocrinol. 2010;31:420–39. doi: 10.1016/j.yfrne.2010.06.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Silva MJ, Samandar E, Preau JL, Needham LL, Calafat AM. Urinary oxidative metabolites of di(2-ethylhexyl) phthalate in humans. Toxicology. 2006;219:22–32. doi: 10.1016/j.tox.2005.10.018. [DOI] [PubMed] [Google Scholar]
  • 67.Frederiksen H, Aksglaede L, Sorensen K, Skakkebaek NE, Juul A, Andersson AM. Urinary excretion of phthalate metabolites in 129 healthy Danish children and adolescents: estimation of daily phthalate intake. Environ Res. 2011;111:656–63. doi: 10.1016/j.envres.2011.03.005. [DOI] [PubMed] [Google Scholar]
  • 68.Frederiksen H, Sorensen K, Mouritsen A, Aksglaede L, Hagen CP, Petersen JH, et al. High urinary phthalate concentration associated with delayed pubarche in girls. Int J Androl. 2012;35:216–26. doi: 10.1111/j.1365-2605.2012.01260.x. [DOI] [PubMed] [Google Scholar]
  • 69.Stroheker T, Cabaton N, Nourdin G, Regnier JF, Lhuguenot JC, Chagnon MC. Evaluation of anti-androgenic activity of di-(2-ethylhexyl)phthalate. Toxicology. 2005;208:115–21. doi: 10.1016/j.tox.2004.11.013. [DOI] [PubMed] [Google Scholar]
  • 70.Hokanson R, Hanneman W, Hennessey M, Donnelly KC, McDonald T, Chowdhary R, et al. DEHP, bis(2)-ethylhexyl phthalate, alters gene expression in human cells: possible correlation with initiation of fetal developmental abnormalities. Hum Exp Toxicol. 2006;25:687–95. doi: 10.1177/0960327106071977. [DOI] [PubMed] [Google Scholar]
  • 71.Durmaz E, Ozmert EN, Erkekoglu P, Giray B, Derman O, Hincal F, et al. Plasma phthalate levels in pubertal gynecomastia. Pediatrics. 2010;125:e122–9. doi: 10.1542/peds.2009-0724. [DOI] [PubMed] [Google Scholar]
  • 72.Takeuchi S, Iida M, Kobayashi S, Jin K, Matsuda T, Kojima H. Differential effects of phthalate esters on transcriptional activities via human estrogen receptors alpha and beta, and androgen receptor. Toxicology. 2005;210:223–33. doi: 10.1016/j.tox.2005.02.002. [DOI] [PubMed] [Google Scholar]
  • 73.Chou YY, Huang PC, Lee CC, Wu MH, Lin SJ. Phthalate exposure in girls during early puberty. J Pediatr Endocrinol Metab. 2009;22:69–77. doi: 10.1515/jpem.2009.22.1.69. [DOI] [PubMed] [Google Scholar]
  • 74.Colon I, Caro D, Bourdony CJ, Rosario O. Identification of phthalate esters in the serum of young Puerto Rican girls with premature breast development. Environ Health Perspect. 2000;108:895–900. doi: 10.1289/ehp.108-2556932. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Lomenick JP, Calafat AM, Melguizo Castro MS, Mier R, Stenger P, Foster MB, et al. Phthalate exposure and precocious puberty in females. J Pediatr. 2010;156:221–5. doi: 10.1016/j.jpeds.2009.09.047. [DOI] [PubMed] [Google Scholar]
  • 76.Kang JH, Kondo F, Katayama Y. Human exposure to bisphenol A. Toxicology. 2006;226:79–89. doi: 10.1016/j.tox.2006.06.009. [DOI] [PubMed] [Google Scholar]
  • 77.Krishnan AV, Stathis P, Permuth SF, Tokes L, Feldman D. Bisphenol-A: an estrogenic substance is released from polycarbonate flasks during autoclaving. Endocrinology. 1993;132:2279–86. doi: 10.1210/endo.132.6.8504731. [DOI] [PubMed] [Google Scholar]
  • 78.Howdeshell KL, Hotchkiss AK, Thayer KA, Vandenbergh JG, vom Saal FS. Exposure to bisphenol A advances puberty. Nature. 1999;401:763–4. doi: 10.1038/44517. [DOI] [PubMed] [Google Scholar]
  • 79.Wolff MS, Teitelbaum SL, Pinney SM, Windham G, Liao L, Biro F, et al. Investigation of relationships between urinary biomarkers of phytoestrogens, phthalates, and phenols and pubertal stages in girls. Environ Health Persp. 2010;118:1039–46. doi: 10.1289/ehp.0901690. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Qiao L, Zheng L, Cai D. Study on the levels of the bisphenol A, octylphenol, 4-nonylphenol in serum of precocious girls. Wei Sheng Yan Jiu. 2010;39:9–12. [PubMed] [Google Scholar]
  • 81.Mnif W, Hassine AI, Bouaziz A, Bartegi A, Thomas O, Roig B. Effect of endocrine disruptor pesticides: a review. Int J Environ Res Public Health. 2011;8:2265–303. doi: 10.3390/ijerph8062265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Turusov V, Rakitsky V, Tomatis L. Dichlorodiphenyltrichloroethane (DDT): ubiquity, persistence, and risks. Environ Health Perspect. 2002;110:125–8. doi: 10.1289/ehp.02110125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Ouyang F, Perry MJ, Venners SA, Chen C, Wang B, Yang F, et al. Serum DDT, age at menarche, and abnormal menstrual cycle length. Occup Environ Med. 2005;62:878–84. doi: 10.1136/oem.2005.020248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Krstevska-Konstantinova M, Charlier C, Craen M, Du Caju M, Heinrichs C, de Beaufort C, et al. Sexual precocity after immigration from developing countries to Belgium: evidence of previous exposure to organochlorine pesticides. Hum Reprod. 2001;16:1020–6. doi: 10.1093/humrep/16.5.1020. [DOI] [PubMed] [Google Scholar]
  • 85.Vasiliu O, Muttineni J, Karmaus W. In utero exposure to organochlorines and age at menarche. Hum Reprod. 2004;19:1506–12. doi: 10.1093/humrep/deh292. [DOI] [PubMed] [Google Scholar]
  • 86.Denham M, Schell LM, Deane G, Gallo MV, Ravenscroft J, DeCaprio AP. Relationship of lead, mercury, mirex, dichlorodiphenyldichloroethylene, hexachlorobenzene, and polychlorinated biphenyls to timing of menarche among Akwesasne Mohawk girls. Pediatrics. 2005;115:e127–34. doi: 10.1542/peds.2004-1161. [DOI] [PubMed] [Google Scholar]
  • 87.Gladen BC, Klebanoff MA, Hediger ML, Katz SH, Barr DB, Davis MD, et al. Pre-natal DDT exposure in relation to anthropometric and pubertal measures in adolescent males. Environ Health Perspect. 2004;112:1761–7. doi: 10.1289/ehp.7287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Donahue SM, Kleinman KP, Gillman MW, Oken E. Trends in birth weight and gestational length among singleton term births in the United States: 1990–2005. Obstet Gynecol. 2010;115:357–64. doi: 10.1097/AOG.0b013e3181cbd5f5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89.Rajender S, Avery K, Agarwal A. Epigenetics, spermatogenesis and male infertility. Mutat Res. 2011;727:62–71. doi: 10.1016/j.mrrev.2011.04.002. [DOI] [PubMed] [Google Scholar]
  • 90.Moline JM, Golden AL, Bar-Chama N, Smith E, Rauch ME, Chapin RE, et al. Exposure to hazardous substances and male reproductive health: a research framework. Environ Health Perspect. 2000;108:803–13. doi: 10.1289/ehp.00108803. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91.Tam CS, de Zegher F, Garnett SP, Baur LA, Cowell CT. Opposing influences of prenatal and postnatal growth on the timing of menarche. J Clin Endocrinol Metab. 2006;91:4369–73. doi: 10.1210/jc.2006-0953. [DOI] [PubMed] [Google Scholar]
  • 92.Ibanez L, Jimenez R, de Zegher F. Early puberty-menarche after precocious pubarche: relation to prenatal growth. Pediatrics. 2006;117:117–21. doi: 10.1542/peds.2005-0664. [DOI] [PubMed] [Google Scholar]
  • 93.Strom BL, Schinnar R, Ziegler EE, Barnhart KT, Sammel MD, Macones GA, et al. Exposure to soy-based formula in infancy and endocrinological and reproductive outcomes in young adulthood. JAMA. 2001;286:807–14. doi: 10.1001/jama.286.7.807. [DOI] [PubMed] [Google Scholar]
  • 94.Giampietro PG, Bruno G, Furcolo G, Casati A, Brunetti E, Spadoni GL, et al. Soy protein formulas in children: no hormonal effects in long-term feeding. J Pediatr Endocrinol Metab. 2004;17:191–6. doi: 10.1515/jpem.2004.17.2.191. [DOI] [PubMed] [Google Scholar]
  • 95.Qiao L, Zheng L, Cai D. Study on the di-n-butyl phthalate and di-2-ethylhexyl phthalate level of girl serum related with precocious puberty in Shanghai. Wei Sheng Yan Jiu. 2007;36:93–5. [PubMed] [Google Scholar]
  • 96.Ozen S, Darcan S, Bayindir P, Karasulu E, Simsek DG, Gurler T. Effects of pesticides used in agriculture on the development of precocious puberty. Environ Monit Assess. 2012;184:4223–32. doi: 10.1007/s10661-011-2257-6. [DOI] [PubMed] [Google Scholar]

RESOURCES